Nav: Home

A new culprit for multiple sclerosis relapses

May 07, 2019

A molecule that helps blood clot may also play a role in multiple sclerosis relapses, researchers report in the May 6 issue of PNAS. The new research may help answer the mystery of why remissions happen, as well as find early markers of the disease.

The research also shows a new way to study multiple sclerosis (MS) in mice that is closer to the human form of the disease.

MS affects about a million people in the United States and many more globally. It damages the brain's ability to communicate with the rest of the body, making it hard to walk, write, or hold a fork and knife. This happens because of damage to the insulation around the nerves. Just like a frayed wire, a nerve with damaged insulation can short out or send bad signals.

But the damage isn't permanent, at least not at first. Most people with multiple sclerosis have recurring episodes of disability, followed by remissions when their symptoms lessen or disappear. Why these relapses and remissions happen is a great mystery. We know that the damage to the nerves is caused by the immune system, the army of cells in our body that is supposed to protect us from disease-causing invaders. For some reason, in MS, the immune system turns on cells in the brain and spinal cord. In MS patients, a particular type of immune cell - CD8+ cells, a part of the immune system that normally kills cells that are cancerous or infected - seem to be the ones doing the damage.

Although researchers have been able to develop drugs to help fight MS using a mouse version of MS, these experimental mice develop a slightly different immune system response than what happens in MS in humans. Different cells do the damage in MS mice: CD4+ cells. The mice have CD8+ cells, but those CD8+ cells are generally quiescent. This has been a big stumbling block to understanding how the immune system develops in MS.

But a team of researchers from UConn Health, the University of Illinois at Chicago (UIC), and the Gladstone Institutes have figured out how CD8+ cells are activated in MS mice, and the result seems very close to what happens in humans. The new findings hinge on how cells talk to each other. Cells will often secrete little bubbles containing proteins and genetic signals. These bubbles are called extracellular vesicles, or EVs. EVs are made by most cells in the body, and float in the blood stream like a message in a bottle.

So the team injected EVs from normal, healthy mice into mice that had that experimental MS-like disease. When they did this, the mice acquired a relapsing-remitting disease and active CD8+ cells, like human MS patients. The researchers examined the EVs in mice and patients with MS and found they contained fibrinogen, a protein that neuroscientist Katerina Akassoglou's lab at Gladstone had been studying in MS. Fibrinogen normally helps blood clot and seal up wounds. But in these MS mice, the EVs with fibrinogen seemed to activate the CD8+ immune cells. When they injected the MS mice with EVs that did not have fibrinogen, they could not cause the relapsing-remitting illness.

"These findings expand our understanding of how fibrinogen contributes to the progression of MS pathology" says Akassoglou, senior investigator at Gladstone and professor of neurology at UC San Francisco. "Fibrinogen in exosomes may have far-reaching implications for therapies and as a biomarker for disease progression in MS and potentially, other neurological diseases," she says. 

"We now have a robust model of relapsing/remitting disease driven by CD8+ cells," says UConn neuroscientist Stephen Crocker, who directed the study. "There's all these clinically important questions we can now ask." Crocker and his colleagues want to study this model further to understand how and why the remissions of disease happen. 

"Understanding the causes of relapses is a key step on the path to a cure for MS," says study co-author Ernesto Bongarzone, an anatomy and cell biology neuroscientist and professor at UIC. "The results of this study and the identification of fibrinogen as a key molecule contributing to relapses are exciting steps forward."

The researchers would like to understand how the fibrinogen stimulates the CD8+ cells that cause the relapsing and remitting disease activity. They would also like to test whether fibrinogen and related proteins found in the EVs also play a role in humans with MS, and test if these molecular signals in EVs might be early warnings of relapses or disease progression.
-end-


University of Connecticut

Related Immune System Articles:

Immune system upgrade
Theoretically, our immune system could detect and kill cancer cells.
Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
First impressions go a long way in the immune system
An algorithm that predicts the immune response to a pathogen could lead to early diagnosis for such diseases as tuberculosis
Filming how our immune system kill bacteria
To kill bacteria in the blood, our immune system relies on nanomachines that can open deadly holes in their targets.
Putting the break on our immune system's response
Researchers have discovered how a tiny molecule known as miR-132 acts as a 'handbrake' on our immune system -- helping us fight infection.
Decoding the human immune system
For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome.
Masterswitch discovered in body's immune system
Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
How a fungus can cripple the immune system
An international research team led by Professor Oliver Werz of Friedrich Schiller University, Jena, has now discovered how the fungus knocks out the immune defenses, enabling a potentially fatal fungal infection to develop.
How the immune system protects us against bowel cancer
Researchers from Charité - Universitätsmedizin Berlin have discovered a protective mechanism which is used by the body to protect intestinal stem cells from turning cancerous.
How herpesviruses shape the immune system
DZIF scientists at the Helmholtz Zentrum München have developed an analytic method that can very precisely detect viral infections using immune responses.
More Immune System News and Immune System Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab